Andy

September 4, 2013

New HIV Vaccine Proves Successful In Phase 1 Human Trial: Commercially Available Soon?

"What is unique about Kang's vaccine is its use of a killed-whole HIV-1- which is similar to the vaccines developed for polio- influenza- and rabies. HIV-1 is also genetically engineered; this raises its safety profile and the possibility of it being produced in large quantities."

New HIV Vaccine Proves Successful In Phase 1 Human Trial: Commercially Available Soon?

Canadian researchers have developed the first genetically modified- whole-killed HIV vaccine- which has successfully passed Phase 1 human trials.